Diversity in
Clinical Research
Quick Facts
It's important for people from all communities to benefit from medical advances.
Why Is Diversity in Clinical Research Important?
Why We Need Your Help?
Frequently Asked
Questions (FAQs)
Toggle FAQs
A clinical research study, also known as a clinical trial, is a medical study that helps to answer important questions about investigational drugs, such as:
Is it safe?
Does it work?
Are there side effects?
All drugs must be tested in clinical research studies before they can be approved for doctors to give to patients. Without people taking part in these studies, we would not have new drugs.
Your wellbeing and safety are the most important parts of a clinical research study.
Before a clinical research study can begin, a team of experts makes sure it is safe and ethical. Ethical means that the study is honest, and fair, and treats people with respect. These experts check that the possible benefits of taking part in the study are greater than the possible risks.
Before you decide if you want to take part in a study, the possible risks will be explained in detail to you. This step is known as “informed consent.”
If you qualify for and agree to participate in the study, you will not have to pay for the investigational drug. In addition, reimbursement for study-related travel expenses may be available.
When the research study is over, the sponsor may seek to publish the results (in a scientific journal, for example). Study results will also be posted on ClinicalTrials.gov after all study participants have completed the study and study data has been analyzed. Your identity will remain confidential and participants will remain anonymous to the sponsor. Only overall summary data results from participants will be publicly shared. Research results will never contain your name and will never publicly report your individual data.
Research studies are designed in specific ways to test investigational drugs for safety and efficacy. One or more of the answers that you provided were outside of the guidelines for the study. This does not mean you will not qualify for different research studies.
Yes, there are placebos in some of these studies. If you prequalify for a study, the study center staff can answer any questions you may have.
Yes, there are placebos in some of these studies. If you prequalify for a study, the study center staff can answer any questions you may have.
This program will be investigating multiple different investigational drugs. If you prequalify, the study center staff can answer any questions you may have.
Do not discontinue any medication unless you are advised to do so by the study center staff or your primary care provider.
Each study in this program has a different schedule. If you prequalify, the study center staff can answer any questions you may have about the study duration and visit schedule. You can also leave a study at any time for any reason.
What is a clinical research study?
A clinical research study, also known as a clinical trial, is a medical study that helps to answer important questions about investigational drugs, such as:
Is it safe?
Does it work?
Are there side effects?
All drugs must be tested in clinical research studies before they can be approved for doctors to give to patients. Without people taking part in these studies, we would not have new drugs.
Are there safety measures for clinical research study participants?
Your wellbeing and safety are the most important parts of a clinical research study.
Before a clinical research study can begin, a team of experts makes sure it is safe and ethical. Ethical means that the study is honest, and fair, and treats people with respect. These experts check that the possible benefits of taking part in the study are greater than the possible risks.
Before you decide if you want to take part in a study, the possible risks will be explained in detail to you. This step is known as “informed consent.”
Does participating in a research study cost me anything?
If you qualify for and agree to participate in the study, you will not have to pay for the investigational drug. In addition, reimbursement for study-related travel expenses may be available.
What happens once the research study is finished?
When the research study is over, the sponsor may seek to publish the results (in a scientific journal, for example). Study results will also be posted on ClinicalTrials.gov after all study participants have completed the study and study data has been analyzed. Your identity will remain confidential and participants will remain anonymous to the sponsor. Only overall summary data results from participants will be publicly shared. Research results will never contain your name and will never publicly report your individual data.
Why did I not qualify for a research study?
Research studies are designed in specific ways to test investigational drugs for safety and efficacy. One or more of the answers that you provided were outside of the guidelines for the study. This does not mean you will not qualify for different research studies.
Is there a placebo in these studies?
Yes, there are placebos in some of these studies. If you prequalify for a study, the study center staff can answer any questions you may have.
What is a placebo?
A placebo is a substance that looks like the investigational drug but contains no active ingredients.
What are the drugs being tested?
This program will be investigating multiple different investigational drugs. If you prequalify, the study center staff can answer any questions you may have.
What about my current medications?
Do not discontinue any medication unless you are advised to do so by the study center staff or your primary care provider.
How long are these research studies?
Each study in this program has a different schedule. If you prequalify, the study center staff can answer any questions you may have about the study duration and visit schedule. You can also leave a study at any time for any reason.
Sources:
1 https://clinicaltrials.gov/about-site/trends-charts
2 Burroughs et. al. Racial and Ethnic Differences in Response to Medicines: Towards Individualized Pharmaceutical Treatment. J. Natl. Med. Assoc. 2002, 94, 1–26.